Physician profile
Cha Vu
NPI 1588196901
$983.51
in general payments reported to CMS, 2019-2025
10 companies · $41.90 in 2025
The $41.90 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.02 · 2020: $316 · 2023: $63.88 · 2024: $546 · 2025: $41.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $546.03 | 2023-2025 | Invisalign, Itero Element, Invisalign System - Lite |
| Patterson Companies, INC. | $149.50 | 2020 | |
| Dentsply Sirona INC | $115.61 | 2020-2024 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Septodont INC. | $54.01 | 2020 | |
| Zimvie INC. | $49.99 | 2024 | |
| Tulsa Dental Products LLC | $16.02 | 2019 | |
| Philips North America LLC | $14.28 | 2023 | |
| Straumann USA LLC | $12.94 | 2023 | |
| Voco America INC. | $12.74 | 2025 | Grandio So Heavy Flow, Grandio So, Voco Retraction Paste |
| Orapharma, A Division of Bausch Health US, LLC | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cha Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.